Showing results (2291-2300 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|January 1, 1994
Postincubation with aclarubicin reverses topoisomerase II mediated DNA cleavage, strand breaks, and cytotoxicity induced by VP-16L N Petersen, P B Jensen, B S Sørensen, et al.Investigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in metastatic breast cancer. A Southwest Oncology Group studyP M Ravdin, S Green, J H Doroshow, et al.Investigational New Drugs|January 1, 1994
Vinorelbine in pre-treated advanced head & neck squamous cell carcinoma. A phase II studyA Testolin, G Recher, V Cristoferi, et al.Investigational New Drugs|January 1, 1994
Phase II study of deoxyspergualin in metastatic breast cancerK Dhingra, V Valero, L Gutierrez, et al.Investigational New Drugs|January 1, 1994
Trimetrexate in advanced hormone-refractory prostate cancer. An ECOG phase II trialR S Witte, B Y Yeap, D L TrumpInvestigational New Drugs|January 1, 1994
Phase II trial of piroxantrone in metastatic gastric adenocarcinomaR Pazdur, B Bready, A J Scalzo, et al.Investigational New Drugs|September 6, 2007
Volociximab, a chimeric integrin alpha5beta1 antibody, inhibits the growth of VX2 tumors in rabbitsVinay Bhaskar, Melvin Fox, Danna Breinberg, et al.Investigational New Drugs|August 1, 1991
Antitumor activity and mechanism of action of the marine compound girodazoleF Lavelle, A Zerial, C Fizames, et al.Investigational New Drugs|August 1, 1991
Phase II study of 2'-deoxycoformycin in patients with renal cell carcinoma. A National Cancer Institute of Canada Clinical Trials Group studyP Venner, E A Eisenhauer, R Wierzbicki, et al.Investigational New Drugs|August 1, 1991
Carboplatinum and cytosine arabinoside in patients with disseminated malignant melanoma. A phase II studyB Jeremic, L Djuric, L MijatovicPageof 372